原发性胆汁性肝硬化的药物治疗

被引:8
作者
张福奎
机构
[1] 首都医科大学附属北京友谊医院肝病中心
关键词
肝硬化:胆汁性; 熊去氧胆酸; 糖皮质激素;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
100201 [内科学];
摘要
熊去氧胆酸是目前治疗原发性胆汁性肝硬化的唯一公认药物,可以改善早期患者的长期预后;对于熊去氧胆酸疗效不佳者迫切需要其他有效治疗药物治疗,但糖皮质激素、免疫抑制药或其他药物的疗效及安全性尚需更多的临床研究证实;终末期患者适合肝移植治疗。本文就原发性胆汁性肝硬化的药物治疗进展进行综述。
引用
收藏
页码:28 / 34
页数:7
相关论文
共 24 条
[1]
Primary biliary cirrhosis [J].
Selmi, Carlo ;
Bowlus, Christopher L. ;
Gershwin, M. Eric ;
Coppel, Ross L. .
LANCET, 2011, 377 (9777) :1600-1609
[2]
Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome [J].
Corpechot, Christophe ;
Chazouilleres, Olivier ;
Poupon, Raoul .
JOURNAL OF HEPATOLOGY, 2011, 55 (06) :1361-1367
[3]
Bezafibrate Treatment of Primary Biliary Cirrhosis Following Incomplete Response to Ursodeoxycholic Acid [J].
Hazzan, Rawi ;
Tur-Kaspa, Ran .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (05) :371-373
[4]
Methotrexate in Patients with Primary Biliary Cirrhosis Who Respond Incompletely to Treatment With Ursodeoxycholic Acid [J].
Kaplan, Marshall M. ;
Bonder, Alan ;
Ruthazer, Robin ;
Bonis, Peter A. L. .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (11) :3207-3217
[5]
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid [J].
Kuiper, Edith M. M. ;
Hansen, Bettina E. ;
de Vries, Richard A. ;
den Ouden-Muller, Jannie W. ;
Van Ditzhuijsen, Theo J. M. ;
Haagsma, Els B. ;
Houben, Martin H. M. G. ;
Witteman, Ben J. M. ;
van Erpecum, Karel J. ;
van Buuren, Henk R. .
GASTROENTEROLOGY, 2009, 136 (04) :1281-1287
[6]
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases [J].
Beuers, Ulrich ;
Boberg, Kirsten M. ;
Chapman, Roger W. ;
Chazouilleres, Olivier ;
Invernizzi, Pietro ;
Jones, David E. J. ;
Lammert, Frank ;
Pares, Albert ;
Trauner, Michael .
JOURNAL OF HEPATOLOGY, 2009, 51 (02) :237-267
[7]
Primary Biliary Cirrhosis [J].
Lindor, Keith D. ;
Gershwin, M. Eric ;
Poupon, Raoul ;
Kaplan, Marshall ;
Bergasa, Nora V. ;
Heathcote, E. Jenny .
HEPATOLOGY, 2009, 50 (01) :291-308
[8]
Moexipril for Treatment of Primary Biliary Cirrhosis in Patients with an Incomplete Response to Ursodeoxycholic Acid [J].
Charatcharoenwitthaya, Phunchai ;
Talwalkar, Jayant A. ;
Angulo, Paul ;
Gossard, Andrea A. ;
Keach, Jill C. ;
Petz, Janice L. ;
Jorgensen, Roberta A. ;
Lindor, Keith D. .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (02) :476-483
[9]
Genetic factors of susceptibility and of severity in primary biliary cirrhosis [J].
Poupon, Raoul ;
Ping, Chen ;
Chretien, Yves ;
Corpechot, Christophe ;
Chazouilleres, Olivier ;
Simon, Tabassome ;
Heath, Simon C. ;
Matsuda, Fumihiko ;
Poupon, Renee E. ;
Housset, Chantal ;
Barbu, Veronique .
JOURNAL OF HEPATOLOGY, 2008, 49 (06) :1038-1045
[10]
Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis [J].
Stanca, Carmen M. ;
Bach, Nancy ;
Allina, Jorge ;
Bodian, Carol ;
Bodenheimer, Henry, Jr. ;
Odin, Joseph A. .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) :1988-1993